Novartis team perseveres to develop more personalized approach to breast cancer therapy.
All treatments that exist today started with patients volunteering to participate in a study and healthcare professionals offering their expertise.
Sandrine Piret-Gérard, Vice President and Head of US Hematology at Novartis, reflects on what’s inspired her career in health care.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.